These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7192659)

  • 41. [Value of biological test for the detection of increased lead uptake in man].
    Van Peteghem T
    Arch Belg Med Soc; 1974 Mar; 32(3):136-66. PubMed ID: 4611349
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effects of lead on the synthesis of free protoporphyrin in peripheral red cells in rabbits].
    GAJDOS A; GAJDOS-TOROK M; PECORA L
    Folia Med (Napoli); 1955 Aug; 38(8):773-6. PubMed ID: 13277558
    [No Abstract]   [Full Text] [Related]  

  • 43. [Porphyrin metabolism in chronic lead poisoning, anemia and non-lead liver diseases].
    Saita G; Moreo L; Croce G
    Med Lav; 1966 Mar; 57(3):167-74. PubMed ID: 5985036
    [No Abstract]   [Full Text] [Related]  

  • 44. Diagnostic value of free erythrocyte porphyrins and blood lead as a screening test for lead exposure.
    Van Peteghem C; Heyndrickx A; Vereecke R
    J Pharm Pharmacol; 1979 Aug; 31(8):551-2. PubMed ID: 39998
    [No Abstract]   [Full Text] [Related]  

  • 45. Biochemical response of male volunteers ingesting inorganic lead for 49 days.
    Cools A; Sallé HJ; Verberk MM; Zielhuis L
    Int Arch Occup Environ Health; 1976 Dec; 38(2):129-39. PubMed ID: 1002305
    [No Abstract]   [Full Text] [Related]  

  • 46. [Diagnosis, clinical biochemistry and therapy of lead poisoning. Demonstration on a classical case].
    Graben N; Bischoff KO; Doss M
    Med Welt; 1977 Mar; 28(11):531-6. PubMed ID: 853916
    [No Abstract]   [Full Text] [Related]  

  • 47. [Biochemical evaluation of damage due to lead: importance and significance of erythrocyte zinc-protoporhyrin IX and urinary amino acid determination].
    Sanguinetti F; Dompè M; Ronca G
    Ann Ist Super Sanita; 1977; 13(1-2):399-407. PubMed ID: 603137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Delta-aminolevulinic acid synthetase and adenosine triphosphate activity in acute saturnine intoxication in rabbits.
    Gajdos A; Gajdos-Török M
    Arch Environ Health; 1971 Oct; 23(4):270-4. PubMed ID: 5111309
    [No Abstract]   [Full Text] [Related]  

  • 49. Erythrocyte copper and prophyrins in lead poisoning.
    RUBINO GF; PAGLIARDI E; PRATO V; GIANGRANDI E
    Br J Haematol; 1958 Jan; 4(1):103-7. PubMed ID: 13499839
    [No Abstract]   [Full Text] [Related]  

  • 50. [Porphyrin metabolism and hematologic diseases in lead poisoning].
    Cotrone D; Fiumi G
    Minerva Med; 1971 Mar; 62(20):1041-8. PubMed ID: 5551791
    [No Abstract]   [Full Text] [Related]  

  • 51. Lead effects on the heme biosynthetic pathway. Relationship to toxicity.
    Moore MR; Goldberg A; Yeung-Laiwah AA
    Ann N Y Acad Sci; 1987; 514():191-203. PubMed ID: 3442384
    [No Abstract]   [Full Text] [Related]  

  • 52. [Chronobiological study of the urinary excretion of delta-aminolevulinic acid in man].
    Botta A; Bruguerolle B; Bartolin R; Bouvenot G
    Rev Med Interne; 1986 Sep; 7(4):421-4. PubMed ID: 3797874
    [No Abstract]   [Full Text] [Related]  

  • 53. [Biochemical and electrophysiological studies in subjects with occupational exposure to lead poisoning].
    Kazibutowska Z; Mierzwa P; Mierzwa E
    Neurol Neurochir Pol; 1979; 13(2):155-62. PubMed ID: 450179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Porphyrin metabolism in chronic saturnism and in various forms of anemia and liver disease unrelated to saturnism.
    Saita G; Moreo L; Croce G
    Panminerva Med; 1966; 8(7):292-4. PubMed ID: 5967056
    [No Abstract]   [Full Text] [Related]  

  • 55. Urinary excretion of porphyrins is increased in patients with HIV-1 infection.
    Fuchs D; Artner-Dworzak E; Hausen A; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
    AIDS; 1990 Apr; 4(4):341-4. PubMed ID: 2350454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lead and delta-aminolevulinic acid in urine: quality control].
    Grisler R; Gobbi A; Colombo G; Colombo R; Valla C
    Med Lav; 1974; 65(5-6):202-5. PubMed ID: 4456167
    [No Abstract]   [Full Text] [Related]  

  • 57. Monopyrroles in porphyria, psychosis and lead exposure.
    Moore MR; Graham DJ
    Int J Biochem; 1980; 12(5-6):827-32. PubMed ID: 6893824
    [No Abstract]   [Full Text] [Related]  

  • 58. Lead-induced abnormalities of porphyrin metabolism. The relationship with iron deficiency.
    Piomelli S; Seaman C; Kapoor S
    Ann N Y Acad Sci; 1987; 514():278-88. PubMed ID: 3327432
    [No Abstract]   [Full Text] [Related]  

  • 59. [Chronic lead exposure. Its repercussion on indicators of heme synthesis and iron metabolism].
    Piedras J; Marín A; López-Karpovitch X; Sánchez-Anzaldo J; Corona D; Molina Recio NY
    Sangre (Barc); 1983; 28(6):738-45. PubMed ID: 6673167
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of sex and of chelation therapy on erythrocyte protoporphyrin and urinary delta-aminolevulinic acid in lead-exposed workers.
    Roels HA; Balis-Jacques MN; Buchet JP; Lauwerys RR
    J Occup Med; 1979 Aug; 21(8):527-39. PubMed ID: 112226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.